Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
15.83
+0.19 (1.21%)
Dec 31, 2024, 4:00 PM EST - Market closed
Keros Therapeutics Employees
Keros Therapeutics had 136 employees as of December 31, 2023. The number of employees increased by 31 or 29.52% compared to the previous year.
Employees
136
Change (1Y)
31
Growth (1Y)
29.52%
Revenue / Employee
$4,787
Profits / Employee
-$1,335,074
Market Cap
641.23M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 136 | 31 | 29.52% |
| Dec 31, 2022 | 105 | 45 | 75.00% |
| Dec 31, 2021 | 60 | 25 | 71.43% |
| Dec 31, 2020 | 35 | 12 | 52.17% |
| Dec 31, 2019 | 23 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
KROS News
- 5 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Keros Therapeutics, Inc. (KROS) And Encourages Shareholders to Reach Out - Accesswire
- 6 days ago - Keros Therapeutics, Inc. (KROS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 6 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Keros Therapeutics, Inc. (KROS) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Keros Therapeutics, Inc. (KROS) Shareholders to Inquire about Securities Investigation - Accesswire
- 9 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Keros Therapeutics, Inc. (KROS) And Encourages Investors to Connect - Accesswire
- 10 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Keros Therapeutics, Inc. (KROS) Stockholders to Inquire about Securities Investigation - Accesswire
- 12 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Keros Therapeutics, Inc. (KROS) and Encourages Investors to Learn More About the Investigation - Accesswire
- 13 days ago - Keros Therapeutics, Inc. (KROS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire